Endocrinology, Vol 135, 1178-1185, Copyright © 1994 by Endocrine Society

ARTICLES

PACE4: a subtilisin-like endoprotease prevalent in the anterior pituitary and regulated by thyroid status

RC Johnson, DN Darlington, TA Hand, BT Bloomquist and RE Mains
Neuroscience Department, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Low stringency screening of a rat hypothalamic complementary DNA library for additional members of the subtilisin-like prohormone convertase (PC) family identified rat PACE4, which is 90% identical to human PACE4 in amino acid sequence, with much lower similarity to rat PC1, PC2, furin, PC4, or PC6. The rat PACE4 sequence has the Asp-His- Ser catalytic site triad, an Arg-Gly-Asp potential integrin binding site, and three potential sites for N-linked glycosylation. Rat PACE4 has a long COOH-terminal region, which is very rich in Cys residues (15%). The unique signal sequence of rat PACE4 mediates translocation across microsomal membranes during in vitro translation and secretion of PACE4 from stably transfected fibroblast cells. Rat PACE4 has a tissue and cell line distribution unlike any reported PC, including human PACE4, with high expression in the anterior pituitary and readily detectable expression in several brain regions, the atrium, and the ventricle; negligible PACE4 messenger RNA (mRNA) is detected in neurointermediate pituitary and many nonneuroendocrine tissues. PACE4 mRNA is prevalent in Buffalo rat liver and GH3 cells and present at low levels in AtT-20 cells, whereas it is undetectable in several other cell lines. In situ hybridization coupled with immunocytochemistry revealed that PACE4 is produced by somatotropes, mammotropes, and corticotropes, whereas less PACE4 mRNA was detected in thyrotropes. PACE4 mRNA levels in anterior pituitary are strikingly regulated by thyroid status, with more than a 10-fold increase seen from hypothyroid to hyperthyroid animals. The prevalence of PACE4 in anterior pituitary and the striking effect of thyroid status on PACE4 expression suggest a specific role for PACE4 in processing neuroendocrine peptides.

This article has been cited by other articles:

				D. E. Bassi, R. Lopez De Cicco, J. Cenna, S. Litwin, E. Cukierman, and A. J.P. Klein-Szanto PACE4 Expression in Mouse Basal Keratinocytes Results in Basement Membrane Disruption and Acceleration of Tumor Progression Cancer Res., August 15, 2005; 65(16): 7310 - 7319. [Abstract] [Full Text] [PDF]

				X. Shen, Q.-L. Li, G. A. Brent, and T. C. Friedman Regulation of regional expression in rat brain PC2 by thyroid hormone/characterization of novel negative thyroid hormone response elements in the PC2 promoter Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E236 - E245. [Abstract] [Full Text] [PDF]

				A. Dey, C. Norrbom, X. Zhu, J. Stein, C. Zhang, K. Ueda, and D. F. Steiner Furin and Prohormone Convertase 1/3 Are Major Convertases in the Processing of Mouse Pro-Growth Hormone-Releasing Hormone Endocrinology, April 1, 2004; 145(4): 1961 - 1971. [Abstract] [Full Text] [PDF]

				H. Mahloogi, D. E. Bassi, and A. J.P. Klein-Szanto Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4 Carcinogenesis, April 1, 2002; 23(4): 565 - 572. [Abstract] [Full Text] [PDF]

				W. Dong and R. Day Gene Expression of Proprotein Convertases in Individual Rat Anterior Pituitary Cells and Their Regulation in Corticotrophs Mediated by Glucocorticoids Endocrinology, January 1, 2002; 143(1): 254 - 262. [Abstract] [Full Text] [PDF]

				D. E. Bassi, R. L. De Cicco, H. Mahloogi, S. Zucker, G. Thomas, and A. J. P. Klein-Szanto Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells PNAS, August 17, 2001; (2001) 191199198. [Abstract] [Full Text] [PDF]

				Q.-L. Li, E. Jansen, G. A. Brent, and T. C. Friedman Regulation of prohormone convertase 1 (PC1) by thyroid hormone Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E160 - E170. [Abstract] [Full Text] [PDF]

				Q.-L. Li, E. Jansen, G. A. Brent, S. Naqvi, J. F. Wilber, and T. C. Friedman Interactions between the Prohormone Convertase 2 Promoter and the Thyroid Hormone Receptor Endocrinology, September 1, 2000; 141(9): 3256 - 3266. [Abstract] [Full Text] [PDF]

				D. B. Constam and E. J. Robertson Regulation of Bone Morphogenetic Protein Activity by Pro Domains and Proprotein Convertases J. Cell Biol., January 11, 1999; 144(1): 139 - 149. [Abstract] [Full Text] [PDF]

				M. R. Alam, R. C. Johnson, D. N. Darlington, T. A. Hand, R. E. Mains, and B. A. Eipper Kalirin, a Cytosolic Protein with Spectrin-like and GDP/GTP Exchange Factor-like Domains That Interacts with Peptidylglycine alpha -Amidating Monooxygenase, an Integral Membrane Peptide-processing Enzyme J. Biol. Chem., May 9, 1997; 272(19): 12667 - 12675. [Abstract] [Full Text] [PDF]

				W. Dong, B. Seidel, M. Marcinkiewicz, M. Chretien, N. G. Seidah, and R. Day Cellular Localization of the Prohormone Convertases in the Hypothalamic Paraventricular and Supraoptic Nuclei: Selective Regulation of PC1 in Corticotrophin-Releasing Hormone Parvocellular Neurons Mediated by Glucocorticoids J. Neurosci., January 15, 1997; 17(2): 563 - 575. [Abstract] [Full Text] [PDF]

				R. C. Johnson, P. Penzes, B. A. Eipper, and R. E. Mains Isoforms of Kalirin, a Neuronal Dbl Family Member, Generated through Use of Different 5'- and 3'-Ends Along with an Internal Translational Initiation Site J. Biol. Chem., June 16, 2000; 275(25): 19324 - 19333. [Abstract] [Full Text] [PDF]

				D. E. Bassi, R. Lopez De Cicco, H. Mahloogi, S. Zucker, G. Thomas, and A. J. P. Klein-Szanto Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells PNAS, August 28, 2001; 98(18): 10326 - 10331. [Abstract] [Full Text] [PDF]